Nvidia faces two key AI infrastructure bottlenecks—power limitations and data center scalability—that the chip giant cannot resolve alone, raising concerns over its…
CoreWeave's earnings forecast could determine whether the recent market selloff extends or reverses, as investors seek confirmation of sustained AI infrastructure growth.
Shares of non-opioid painkiller maker Latigo rose modestly after its upsized IPO, signaling investor interest in the biotech's pain management solutions.
India's top bank tops earnings forecasts as loan growth fuels share price rally, boosting investor sentiment in the financial sector.
Japan's GPIF reports record $152 billion gain fueled by stock market rally, highlighting pension funds' growing reliance on equities.
BlossomHill's $150 million IPO, backed by Janus Henderson, underscored biotech demand and could lift Janus Henderson's stock on the back of a…
Latigo's $345.6 million IPO highlights Wall Street's bet on non-opioid pain therapies, marking a significant entry for the biotech firm into public…
Zillow revenue jump highlights rental platform strength, as the real estate tech firm navigates a cooling housing market with diversified offerings.
US stocks hit record highs while the VIX fear gauge displays an unusual correlation, moving together only 20% of the time—a rare…
Attovia Therapeutics stock jumps 24% in trading debut after $289 million biotech IPO, reflecting strong demand for new healthcare listings.
Galaxy Digital Q2 net loss of $85M and revenue miss underscore crypto market headwinds, with falling digital asset prices weighing on the…
Nearly two-thirds of young male daily stock traders feel like failures, underscoring the psychological risks of high-frequency retail trading in an environment…